← Back to Search

Ultrasound for Kidney Stones Detection

N/A
Recruiting
Led By Thomas Chi, M.D.
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing how well ultrasound works to find kidney stone fragments, compared to the current standard (fluoroscopy).

Who is the study for?
This trial is for adults over 18 with diagnosed renal or ureteral stones scheduled for retrograde intrarenal surgery (RIRS). It's not suitable for patients having bilateral stone removal, those who refuse consent, pregnant women, kidney transplant recipients, individuals with ectopic kidneys, or if pain can't be managed in the ER.
What is being tested?
The study aims to compare the effectiveness of ultrasound versus traditional fluoroscopy in detecting remaining stone fragments during RIRS. The goal is to reduce radiation exposure and enhance care quality for patients and healthcare teams.
What are the potential side effects?
While the trial focuses on imaging techniques rather than medications, potential side effects may include discomfort from ultrasound application or complications related to incorrect detection of residual stones.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Diagnostic accuracy detecting residual fragments during retrograde intrarenal surgery
Secondary study objectives
Negative predictive value detecting residual fragments during retrograde intrarenal surgery
Operative time in minutes
Positive predictive value detecting residual fragments during retrograde intrarenal surgery
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: UltrasoundExperimental Treatment1 Intervention
Before completing retrograde intrarenal surgery, a complete endoscopic examination will be performed along with ultrasound by the same endourologist to determine the size of the largest residual fragment.
Group II: FluoroscopyActive Control1 Intervention
Standard of care, control Before completing retrograde intrarenal surgery, a complete endoscopic examination will be performed along with fluoroscopy by the same endourologist to determine the size of the largest residual fragment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrasound
2013
Completed Phase 1
~4090

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,593 Previous Clinical Trials
14,887,778 Total Patients Enrolled
4 Trials studying Kidney Stones
3,759 Patients Enrolled for Kidney Stones
Thomas Chi, M.D.Principal InvestigatorUniversity of California, San Francisco
1 Previous Clinical Trials
100 Total Patients Enrolled

Media Library

Ultrasound Clinical Trial Eligibility Overview. Trial Name: NCT05535816 — N/A
Kidney Stones Research Study Groups: Ultrasound, Fluoroscopy
Kidney Stones Clinical Trial 2023: Ultrasound Highlights & Side Effects. Trial Name: NCT05535816 — N/A
Ultrasound 2023 Treatment Timeline for Medical Study. Trial Name: NCT05535816 — N/A
~55 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top